TABLE OF CONTENTS
1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 OVERVIEW OF GLOBAL RADIOTHERAPY MARKET 24
1.3 CURRENCY AND PRICING 25
1.3.1 LIMITATION 25
1.3.2 MARKETS COVERED 25
2 MARKET SEGMENTATION 28
2.1 MARKETS COVERED 28
2.2 GEOGRAPHIC SCOPE 29
2.3 YEARS CONSIDERED FOR THE STUDY 30
2.4 CURRENCY AND PRICING 30
2.5 RESEARCH METHODOLOGY 31
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34
2.7 DBMR MARKET CHALLENGE MATRIX 35
2.8 SECONDARY SOURCES 36
2.9 ASSUMPTIONS 36
3 MARKET OVERVIEW 37
3.1 DRIVERS 39
3.1.1 GROWING INCIDNECE OF CANCER 39
3.1.2 RISING AGEING POPULATION 39
3.1.3 UNHEALTHY LIFESTYLE 40
3.1.4 MERGERS AND ACQUISITIONS TO EXPAND BUSINESS 40
3.2 RESTRAINTS 41
3.2.1 REGULATORY SCENARIO 41
3.2.2 HIGH COST OF RADIOTHERAPY 41
3.3 OPPORTUNITIES 41
3.3.1 EMERGING MARKET 41
3.4 CHALLENGES 42
3.4.1 SIDE-EFFECTS OF RADIOTHERAPY 42
3.4.2 REQUIREMENT OF TRAINED STAFF 42
4 EXECUTIVE SUMMARY 43
5 PREMIUM INSIGHTS 46
5.1 INCREASING GOVERNMENT FUNDING AND TECHNOLOGICAL ADVANCEMENT IS EXPECTED TO DRIVE THE MARKET FOR RADIOTHERAPY IN THE FORECAST PERIOD 2018 TO 2025 46
6 GLOBAL RADIOTHERAPY MARKET, BY THERAPY TYPE 48
6.1 OVERVIEW 49
6.2 BEAM RADIOTHERAPY 51
6.2.1 IGRT 52
6.2.2 IMRT 52
6.2.3 STEREOTACTIC TECHNOLOGY 52
6.2.4 TOMOTHERAPY 52
6.2.5 3D CONFORMAL RADIOTHERAPY 52
6.2.6 VMAT 52
6.3 BRACHYTHERAPY 53
6.3.1 LDR 54
6.3.2 HDR 54
6.4 SYSTEMIC RADIOTHERAPY 54
7 GLOBAL RADIOTHERAPY MARKET, BY PRODUCT TYPE 55
7.1 OVERVIEW 56
7.2 EXTERNAL BEAM RADIOTHERAPY 58
7.2.1 LINAC 59
7.2.2 CYBER KNIFE 59
7.2.3 PROTON THERAPY 59
7.2.3.1 CYCLOTRON 59
7.2.3.2 SYNCLOTRON 59
7.2.4 GAMMA KNIFE 59
7.3 INTERNAL RADIOTHERAPY PRODUCTS 59
7.3.1 SEEDS 60
7.3.2 AFTERLOADERS 60
7.4 RADIOTHERAPY SOFTWARE 61
7.4.1 TREATMENT PLANNING SOFTWARE 62
7.4.2 DOSAGE PLANNING SOFTWARE 62
7.4.3 PATIENT POSITIONING SOFTWARE 62
7.4.4 IMAGE GUIDING SOFTWARE 62
7.5 SYSTEMIC RADIOTHERAPY 63
8 GLOBAL RADIOTHERAPY MARKET, BY APPLICATION 64
8.1 OVERVIEW 65
8.2 PROSTATE CANCER 67
8.3 BREAST CANCER 68
8.4 LUNG CANCER 69
8.5 SPINE CANCER 69
8.6 LIVER CANCER 70
8.7 BRAIN CANCER 70
8.8 OTHERS 71
9 GLOBAL RADIOTHERAPY MARKET, BY GEOGRAPHY 72
9.1 OVERVIEW 73
9.2 NORTH AMERICA 78
9.2.1 U.S. 85
9.2.2 CANADA 89
9.2.3 MEXICO 93
9.3 EUROPE 97
9.3.1 GERMANY 105
9.3.2 U.K. 109
9.3.3 FRANCE 113
9.3.4 ITALY 117
9.3.5 SPAIN 121
9.3.6 SWITZERLAND 125
9.3.7 NETHERLANDS 129
9.3.8 BELGIUM 133
9.3.9 RUSSIA 137
9.3.10 TURKEY 141
9.3.11 REST OF EUROPE 145
9.4 ASIA-PACIFIC 146
9.4.1 CHINA 154
9.4.2 JAPAN 158
9.4.3 INDIA 162
9.4.4 SOUTH KOREA 166
9.4.5 AUSTRALIA 170
9.4.6 SINGAPORE 174
9.4.7 THAILAND 178
9.4.8 MALAYSIA 182
9.4.9 INDONESIA 186
9.4.10 PHILIPPINES 190
9.4.11 REST OF ASIA-PACIFIC 194
9.5 SOUTH AMERICA 195
9.5.1 BRAZIL 201
9.5.2 REST OF SOUTH AMERICA 206
9.6 MIDDLE EAST & AFRICA 207
9.6.1 SOUTH AFRICA 214
9.6.2 REST OF MIDDLE EAST & AFRICA 218
?
10 GLOBAL RADIOTHERAPY MARKET, COMPANY LANDSCAPE 219
10.1 COMPANY SHARE ANALYSIS; GLOBAL 219
10.2 COMPANY SHARE ANALYSIS; NORTH AMERICA 220
10.3 COMPANY SHARE ANALYSIS; EUROPE 221
10.4 COMPANY SHARE ANALYSIS; ASIA-PACIFIC 222
11 COMPANY PROFILES 223
11.1 VARIAN MEDICAL SYSTEMS, INC. 223
11.1.1 COMPANY OVERVIEW 223
11.1.2 REVENUE ANALYSIS 224
11.1.3 PRODUCT PORTFOLIO 225
11.2 ELEKTA AB 226
11.2.1 COMPANY OVERVIEW 226
11.2.2 REVENUE ANALYSIS 226
11.2.3 PRODUCT PORTFOLIO 227
11.2.4 RECENT DEVELOPMENTS 229
11.3 ACCURAY, INC. 230
11.3.1 COMPANY OVERVIEW 230
11.3.2 REVENUE ANALYSIS 230
11.3.3 PRODUCT PORTFOLIO 231
11.3.4 RECENT DEVELOPMENTS 232
11.4 BRAINLAB AG 233
11.4.1 COMPANY OVERVIEW 233
11.4.2 PRODUCT PORTFOLIO 233
11.4.3 RECENT DEVELOPMENTS 234
11.5 ION BEAM APPLICATIONS SA 235
11.5.1 COMPANY OVERVIEW 235
11.5.2 REVENUE ANALYSIS 235
11.5.3 PRODUCT PORTFOLIO 236
11.5.4 RECENT DEVELOPMENTS 236
11.6 ISORAY MEDICAL, INC. 237
11.6.1 COMPANY OVERVIEW 237
11.6.2 PRODUCT PORTFOLIO 237
11.6.3 RECENT DEVELOPMENTS 237
11.6.4 RECENT DEVELOPMENTS 238
11.7 MEVION MEDICAL SYSTEMS, INC. 239
11.7.1 COMPANY OVERVIEW 239
11.7.2 PRODUCT PORTFOLIO 239
11.7.3 RECENT DEVELOPMENTS 239
?
11.8 NANOBIOTIX 240
11.8.1 COMPANY OVERVIEW 240
11.8.2 REVENUE ANALYSIS 240
11.8.3 PRODUCT PORTFOLIO 240
11.8.4 RECENT DEVELOPMENTS 241
11.9 NORDION (CANADA) INC. 242
11.9.1 COMPANY OVERVIEW 242
11.9.2 PRODUCT PORTFOLIO 242
11.9.3 RECENT DEVELOPMENTS 242
11.10 PRECISIS AG 243
11.10.1 COMPANY OVERVIEW 243
11.10.2 PRODUCT PORTFOLIO 243
11.10.3 RECENT DEVELOPMENTS 243
11.11 RAYSEARCH LABORATORIES AB 244
11.11.1 COMPANY OVERVIEW 244
11.11.2 REVENUE ANALYSIS 244
11.11.3 PRODUCT PORTFOLIO 245
11.11.4 RECENT DEVELOPMENTS 245
12 RELATED REPORTS 246